NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update
Provided By GlobeNewswire
Last update: Feb 26, 2025
-- EMA submission expected in 2H25 by partner Menarini --
-- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025 --
Read more at globenewswire.comNASDAQ:NAMS (9/11/2025, 12:55:58 PM)
25.83
-1.07 (-3.98%)
NASDAQ:NAMSW (9/9/2025, 8:00:02 PM)
15.25
+1.73 (+12.8%)
Find more stocks in the Stock Screener
